For MDA-MB-231, similar average contact times were observed for all conditions where target cells were killed (Fig. 5C), suggesting checkpoint inhibition did not significantly impact the duration of time needed for CD8+ T cells to kill MDA-MB-231 breast cancer cells. Here, CD8A is linked to breast carcinoma.